Skip to main content
. 2018 Dec 12;10:247–264. doi: 10.1016/j.isci.2018.11.029

Figure 1.

Figure 1

CellMinerCDB Overview

(A) CellMinerCDB integrates cancer cell line information from principal resources and provides powerful, user-friendly analysis tools.

(B) Summary of molecular and drug activity data for the five data sources currently included in CellMinerCDB. For molecular data types, the numbers indicate the number of genes with a particular data type. GDSC gene-level mutation and methylation data (numbers in red) were prepared from raw data as part of the development of CellMinerCDB. Asterisks indicate molecular data under development, but not publicly available. Protein expression was determined by reverse-phase protein array.

(C) Cell line and drug overlaps between data sources.

(D) Drug overlaps between data sources.

(E) Small cell lung cancer (SCLC) cell line overlaps between data sources.

(F) SCLC cell line-tested drug overlaps between data sources.